Showing results (61-70 of 260) with videos related to

Sort By:
Pageof 26
Frontiers in Immunology|January 30, 2025
The impact of signaling pathways on the desmosome ultrastructure in pemphigusThomas Schmitt, Julia Huber, Julia Pircher, et al.
Frontiers in Immunology|October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology|December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Dermatology (Basel, Switzerland)|June 19, 2013
Concomitant bullous pemphigoid and dermatitis herpetiformisFranziska Schulze, Nina van Beek, Patrick Terheyden, et al.
International Journal of Dermatology|May 3, 2024
Risk and timing of isotretinoin-related laboratory disturbances: a population-based studyShirin Emtenani, Mariam Abdelghaffar, Ralf J Ludwig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2010
Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodiesVolker Spindler, Franziska Vielmuth, Enno Schmidt, et al.
Trends in Molecular Medicine|July 9, 2013
Emerging treatments for pemphigoid diseasesRalf J Ludwig, Kathrin Kalies, Jörg Köhl, et al.
The British Journal of Dermatology|August 25, 2025
Anti-p200 pemphigoidMichael Kasperkiewicz, Manuela Pigors, Maike M Holtsche, et al.
Pageof 26